Mobile game targets improved outcomes in young cancer patients

HopeLab has released a new mobile game for children with cancer to play during chemotherapy, seeking to improve adherence to meds and spark positive thoughts during treatment. The game, called Re-Mission 2: Nanobot's Revenge, is free and available for Android and Apple iOS devices. Cigna has signed on to help promote HopeLab's mobile game. Release

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.